Genmab A/S (GMAB)
32.32
+1.08
(+3.46%)
USD |
NASDAQ |
Dec 11, 16:00
32.32
0.00 (0.00%)
After-Hours: 18:17
Genmab Total Assets (Quarterly): 7.021B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merus NV | 904.20M |
| Johnson & Johnson | 192.82B |
| Novo Nordisk A/S | 80.64B |
| Ascendis Pharma A/S | 1.357B |
| Evaxion AS | 25.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.270B |
| Shareholders Equity (Quarterly) | 5.751B |
| Debt to Equity Ratio | 0.0247 |
| Current Ratio | 6.034 |
| Net Debt Paydown Yield | 0.00% |